Signal Advisors Wealth LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,408 shares of the healthcare conglomerate's stock after acquiring an additional 2,293 shares during the quarter. Signal Advisors Wealth LLC's holdings in UnitedHealth Group were worth $5,975,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Capital & Planning LLC increased its holdings in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after buying an additional 79 shares in the last quarter. Brighton Jones LLC increased its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new position in UnitedHealth Group in the fourth quarter valued at about $27,233,000. Revolve Wealth Partners LLC increased its holdings in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares in the last quarter. Finally, Money Concepts Capital Corp grew its position in shares of UnitedHealth Group by 1.4% in the fourth quarter. Money Concepts Capital Corp now owns 3,800 shares of the healthcare conglomerate's stock valued at $1,922,000 after purchasing an additional 54 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. Corporate insiders own 0.33% of the company's stock.
UnitedHealth Group Price Performance
UNH opened at $295.61 on Friday. The company has a fifty day simple moving average of $413.43 and a 200 day simple moving average of $486.09. The firm has a market cap of $268.16 billion, a price-to-earnings ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.99%. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on UNH shares. Barclays lowered their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday, May 15th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, KeyCorp decreased their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $428.43.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report